Random Posts
- Gestational Diabetes - Advice
- Dangerous Blood Sugar Levels - What to Do
- How to Lower Blood Sugar Levels - Follow the Tips to Make it Easy
- Diabetes Management - Implementing the Proper Methods and Tools
- Lower Your Blood Sugar Levels to Prevent Diabetic Nerve Damage
- 5 Signs of Pre Diabetes
- Resveratrol and Diabetes
Prescription Diabetes Drugs
What Diet Will Help Type 2 Diabetics Lose Weight Up to 30 to 40 Pounds and Reverse Diabetes
Posted by admin in Prescription Diabetes Drugs on December 31st, 2010
The treatment for type 2 diabetes is the diabetic meal plan. This is the most effective treatment. The diabetic diet will allow you to lose those extra pounds, lower your cholesterol and reverse your diabetes.
Example of weight loss diets below:
Low Fat Low Cholesterol Diet - very low fat diet to help you lose weight and lower cholesterol
Fasting - giving up food for a period of time for weight loss. This one is pretty drastic and usually not recommended for a diabetic.
Atkins Diet - reducing your carbohydrates but allow fats.
South Beach - lower carbohydrates and lower fats
There are many options to lose weight but there is one diabetic meal plan that has been released by corporations to help you lose weight and reverse your diabetes and it is free online.
This diet will give you the right amount of calories and fat to help you lose weight, but allow you keep your energy for everyday tasks.
The most important part of this diet if that if you strictly adhere to this diet then you will lose 30 to 40 pounds, reduce your blood sugar and lower your cholesterol.
Even losing a little weight will reduce your blood glucose, blood pressure and cholesterol.
Make an effort to look at any fat that you might have in your diet. Read the labels in the grocery store so you will know exactly what you should or should not eat.
Allow yourself to lose 30 to 40 pounds, reduce your cholesterol, reduce your blood pressure and reverse your diabetes. Feel better than you have felt in a long time. Free Online.
What is the Key For a Type 2 Diabetic to Lose Weight? Free Online
Posted by admin in Prescription Diabetes Drugs on December 31st, 2010
What is the key to losing weight if you are a type 2 diabetic? Reducing your calories is the number one way to lose weight. You can look at many other diets but the truth is that reduction of calories is the first and foremost way to lose weight.
In this country today the portion size of food has increased dramatically and in so doing so has our calorie intake. The next time you eat out cut that portion into a third and carry the rest home or let someone share your meal with you. You can save money and save calories.
How many calories do you need a day? Multiply your weight by 10. (Example 140 pounds = 1400 calories).
If you are very active male then you might want to add 40% more in calories.
What can weight reduction do for you?
Lower your blood pressure
Lower your blood cholesterol
Lower your blood sugar
Reduce your risk of progression of prediabetes to diabetes
There are companies that have released diabetic meal plans due to the epidemic of obesity and type 2 diabetes.
The meal plans will help you reduce your calories, lose up to 30 to 40 pounds, and reverse your diabetes. This company makes that diet simple for you.
You will know exactly what you need to do to lose those extra pounds and reverse your diabetes.
Also consider adding fiber to your diet as it will help lower your cholesterol. Fiber is in fruits and vegetables and whole grains. This will be also discussed in your diabetic meal plan.
Take that first step in changing your health for the better.
Posted by admin in Prescription Diabetes Drugs on December 31st, 2010
The increased spending on healthcare for Type 2 diabetes in recent years appears to be of value in terms of the adverse outcomes prevented, according to a study published in the Annals of Internal Medicine.
Joseph Newhouse (Harvard Medical School, Boston, Massachusetts, USA) and colleagues explain that chronic diseases account for a large share of total healthcare spending, but it is uncertain whether increases in spending always buy better outcomes for patients.
To address this issue, the researchers performed an economic analysis using data from an observational cohort of 613 Mayo Clinic patients with Type 2 diabetes to determine the net value of healthcare for this population.
The authors assessed changes in inflation-adjusted annual healthcare spending and in health status between 1997 and 2005. Two approaches were used to determine change in health status: 10-year risk for nonfatal and fatal coronary heart disease, and changes in each patient’s predicted remaining life expectancy and quality-adjusted life-years (QALY).
Spending data were obtained for all medical care, whether or not related to patients’ diagnosis of diabetes.
The authors defined net value as the present discounted monetary value of improved survival and avoided treatment spending for coronary heart disease minus the increase in annual spending per patient.
During the study period, control of coronary risk factors such as glycated hemoglobin, blood pressure, and serum lipids, improved with a consequent decrease in modifiable 10-year risk estimates.
Overall, there was a mean increase in predicted life expectancy and QALYs based on all diabetes-related complications of 0.123 years and 0.087 years, respectively.
Total spending during the study period more than doubled, with the greatest increases for inpatient services and pharmacy costs (142% for both).
Assuming that 1 life-year is worth $200,000 (€136,444) and accounting for changes in modifiable cardiovascular risk, the authors estimated the net value of changes in healthcare for patients with Type 2 diabetes as $10,911 (€7,444) per patient between 1997 and 2005.
“A positive dollar value that suggests the value of healthcare has improved despite increased spending,” explain the authors. Estimates remained positive when values of $100,000 (€68,222) and $300,000 (€204,666) were used.
A second approach based on diabetes complications yielded a net value of $6931 (€4,728) per patient.
“We estimate that the value of improved survival from lower cardiovascular risks exceeds or approximates the increased spending on care,” write the authors, although they caution that the estimates are based on a small group of patients and on many assumptions.
In their conclusions, they acknowledge that it is unlikely that the current spending increases can be sustained. “It is still necessary to enhance value for money spent on care for patients with chronic conditions such as diabetes,” they write.
MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a part of Springer Science+Business Media. © Current Medicine Group Ltd; 2009
